Menu
Annual · values202520242023202220212020201920182017201620152014
Operating Cash Flow1.65 M USD-492000 USD827000 USD-3.23 M USD-1.42 M USD-6.90 M USD-2.28 M USD-3.66 M USD-77000 USD-2.11 M USD-3.81 M USD-2.50 M USD
Depreciation & Amortization140000 USD135000 USD214000 USD218000 USD202000 USD192000 USD186000 USD163000 USD218000 USD19000 USD1000 USD6000 USD
Stock-Based Compensation296000 USD153000 USD1.05 M USD982000 USD1.26 M USD779000 USD1.33 M USD985000 USD772000 USD551000 USD489000 USD
Capital Expenditures55000 USD75000 USD137000 USD36000 USD239000 USD14000 USD45000 USD13000 USD
Cash Flow from Investing0 USD-50000 USD-75000 USD-137000 USD-85000 USD-239000 USD-151000 USD-991000 USD-45000 USD-13000 USD0 USD
Cash Flow from Financing-5000 USD-5000 USD-79000 USD34000 USD237000 USD11.22 M USD2.02 M USD7.05 M USD1.99 M USD1.19 M USD3.79 M USD3.20 M USD
Dividends Paid
Stock Buybacks
Free Cash Flow-547000 USD752000 USD-3.37 M USD-1.45 M USD-7.14 M USD-2.29 M USD-2.16 M USD-3.83 M USD

Nephros Inc. is a company that specializes in the development and sale of filtration and ultrafiltration devices. Primarily focusing on providing high-quality, robust filtration solutions, Nephros serves medical institutions, commercial facilities, and the military sector. The company's product portfolio includes hemodiafilters and ultrafilters, which are integral in kidney dialysis and ensuring water is adequately purified for various healthcare and industrial applications. Nephros's technological advancements in filtration enhance safety and operational efficiency, impacting sectors like healthcare equipment manufacturing, water treatment, and hospitality services. By addressing the critical need for clean water and advanced dialysis treatments, Nephros plays a vital role in both enhancing public health standards and improving patient outcomes in medical settings.